These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35001643)

  • 1. Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial.
    Najib U; Smith T; Hindiyeh N; Saper J; Nye B; Ashina S; McClure CK; Marmura MJ; Chase S; Liebler E; Lipton RB
    Cephalalgia; 2022 Jun; 42(7):560-569. PubMed ID: 35001643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
    Diener HC; Goadsby PJ; Ashina M; Al-Karagholi MA; Sinclair A; Mitsikostas D; Magis D; Pozo-Rosich P; Irimia Sieira P; Làinez MJ; Gaul C; Silver N; Hoffmann J; Marin J; Liebler E; Ferrari MD
    Cephalalgia; 2019 Oct; 39(12):1475-1487. PubMed ID: 31522546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.
    Martelletti P; Barbanti P; Grazzi L; Pierangeli G; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Tassorelli C; Liebler E; de Tommaso M;
    J Headache Pain; 2018 Nov; 19(1):101. PubMed ID: 30382909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.
    Grazzi L; Tassorelli C; de Tommaso M; Pierangeli G; Martelletti P; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Liebler E; Barbanti P;
    J Headache Pain; 2018 Oct; 19(1):98. PubMed ID: 30340460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial.
    Tepper SJ; Grosberg B; Daniel O; Kuruvilla DE; Vainstein G; Deutsch L; Sharon R
    Headache; 2022 Sep; 62(8):989-1001. PubMed ID: 35748757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.
    Silberstein SD; Calhoun AH; Lipton RB; Grosberg BM; Cady RK; Dorlas S; Simmons KA; Mullin C; Liebler EJ; Goadsby PJ; Saper JR;
    Neurology; 2016 Aug; 87(5):529-38. PubMed ID: 27412146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
    Chou DE; Shnayderman Yugrakh M; Winegarner D; Rowe V; Kuruvilla D; Schoenen J
    Cephalalgia; 2019 Jan; 39(1):3-14. PubMed ID: 30449151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study.
    Grazzi L; Egeo G; Calhoun AH; McClure CK; Liebler E; Barbanti P
    J Headache Pain; 2016 Dec; 17(1):91. PubMed ID: 27699586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study.
    Goadsby PJ; de Coo IF; Silver N; Tyagi A; Ahmed F; Gaul C; Jensen RH; Diener HC; Solbach K; Straube A; Liebler E; Marin JC; Ferrari MD;
    Cephalalgia; 2018 Apr; 38(5):959-969. PubMed ID: 29231763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM).
    Kuruvilla DE; Mann JI; Tepper SJ; Starling AJ; Panza G; Johnson MAL
    Sci Rep; 2022 Mar; 12(1):5110. PubMed ID: 35332216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.
    Tassorelli C; Grazzi L; de Tommaso M; Pierangeli G; Martelletti P; Rainero I; Dorlas S; Geppetti P; Ambrosini A; Sarchielli P; Liebler E; Barbanti P;
    Neurology; 2018 Jul; 91(4):e364-e373. PubMed ID: 29907608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
    Reuter U; Goadsby PJ; Lanteri-Minet M; Wen S; Hours-Zesiger P; Ferrari MD; Klatt J
    Lancet; 2018 Nov; 392(10161):2280-2287. PubMed ID: 30360965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
    Lipton RB; Dodick DW; Silberstein SD; Saper JR; Aurora SK; Pearlman SH; Fischell RE; Ruppel PL; Goadsby PJ
    Lancet Neurol; 2010 Apr; 9(4):373-80. PubMed ID: 20206581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02).
    Bauer S; Baier H; Baumgartner C; Bohlmann K; Fauser S; Graf W; Hillenbrand B; Hirsch M; Last C; Lerche H; Mayer T; Schulze-Bonhage A; Steinhoff BJ; Weber Y; Hartlep A; Rosenow F; Hamer HM
    Brain Stimul; 2016; 9(3):356-363. PubMed ID: 27033012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial.
    Daniel O; Tepper SJ; Deutsch L; Sharon R
    Pain Ther; 2022 Sep; 11(3):907-922. PubMed ID: 35661128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.
    Silberstein SD; Mechtler LL; Kudrow DB; Calhoun AH; McClure C; Saper JR; Liebler EJ; Rubenstein Engel E; Tepper SJ;
    Headache; 2016 Sep; 56(8):1317-32. PubMed ID: 27593728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial.
    Spierings ELH; Kärppä M; Ning X; Cohen JM; Campos VR; Yang R; Reuter U
    J Headache Pain; 2021 Apr; 22(1):26. PubMed ID: 33863272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial.
    Ji T; Yang Z; Liu Q; Liao J; Yin F; Chen Y; Zou L; Li B; Gao Y; Shu X; Huang S; Gao F; Liang J; Lin SF; Peng J; Song S; Wang J; Che C; Sun W; Tian M; Yang L; Hua Y; Hao Y; Cai L; Li L; Jiang Y
    Trials; 2019 Jan; 20(1):44. PubMed ID: 30642370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.
    Lipton RB; Pozo-Rosich P; Blumenfeld AM; Dodick DW; McAllister P; Li Y; Lu K; Dabruzzo B; Miceli R; Severt L; Finnegan M; Trugman JM
    JAMA Netw Open; 2022 Jun; 5(6):e2215499. PubMed ID: 35675076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
    Bigal ME; Dodick DW; Rapoport AM; Silberstein SD; Ma Y; Yang R; Loupe PS; Burstein R; Newman LC; Lipton RB
    Lancet Neurol; 2015 Nov; 14(11):1081-90. PubMed ID: 26432182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.